Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Research|June 17, 2005
Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosisFrance Docquier, Dawn Farrar, Vivien D'Arcy, et al.
Genome Research|July 17, 2004
The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wideRituparna Mukhopadhyay, WenQiang Yu, Joanne Whitehead, et al.
Nature Genetics|September 14, 2004
Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulationWenqiang Yu, Vasudeva Ginjala, Vinod Pant, et al.
Molecular Cancer Therapeutics|February 28, 2018
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast CancerChrysiis Michaloglou, Claire Crafter, Rasmus Siersbaek, et al.
Cell Reports|February 24, 2021
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regionsRebecca Broome, Igor Chernukhin, Stacey Jamieson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Molecular and Cellular Biology|January 11, 2007
CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wideIgor Chernukhin, Shaharum Shamsuddin, Sung Yun Kang, et al.
Oncogene|June 27, 2020
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driverNatascha Hruschka, Mark Kalisz, Maria Subijana, et al.
Cancer Cell|July 18, 2020
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer MetastasisRasmus Siersbæk, Valentina Scabia, Sankari Nagarajan, et al.
Nature Genetics|January 9, 2020
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Pageof 4